| Name | Title | Contact Details |
|---|
eDoctrina Corporation provides a suite of education management software that supports standards-based planning, curriculum mapping, assessment, data reporting, teacher observation and teacher evaluation.
PrognoCIS Electronic Health Records (EHR) software and mobile apps, telemedicine, medical billing & Revenue Cycle Management for ambulatory specialties.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Certificials Insurance Verification Platform allows Companies to digitally request their Suppliers insurance coverage, and continuously monitor coverage for changes.